OTC Pharmaceuticals in Hungary

over-the-counter(a) pharmaceuticals: international market ingress in Hungary\n\nGGSB, Moscow MBA\nexecutive summary\nHungary is one of the locomote emerging markets in primaeval and Eastern Europe. It is part of European Union which simplifies regulation and grapple when entering the market. Hungary has favorable pickle and advanced infrastructure in terms of logistics, established partners, behavior science companies.\n nonprescription(a) address of the total European pharma has a long transit record of solid appendage, ofttimes at double-digit rates, consistently outperforming the pharmaceutical sector. Evidence-based attention forecasts show commercialized potential.\nGreater promotion of self-medication, change magnitude access through expanding conduct of distribution, national healthcare organisations focus on reducing budgets make OTC market attractive for bracing entrants.\nHowever to be sure-fire in long term, a company should build entrance enter, dist ribution and promotion scheme, which embroil thorough selection of products, measure of gateway, innovative distribution transmit and selling technologies.\nOTC pharma market in Hungary has veritable entry barriers; however opportunities for approaching growth and market expansion deserve not to be overlooked.\n\nTable of Contents\nPharmaceutical industry in Hungary overview 4\nAnalysis of market entry portfolio 7\nEntry system 9\nDistribution strategy 11\nPromotion and marketing communication 12\n set 14\nPotential risks and opportunities 15\nConclusions and recommendations 16\nBibliography 18\n appurtenance 20\n\nPharmaceutical industry in Hungary overview\nHungarian tribe is around 10M people. More than 72% of population is urban. Hungary has relatively impression gross domestic product per capita (Hungary: $11430; compared to UK: $37955; Germany: $38291; France: $34140) and significant growth potential (in last 5 years average GDP growth rate is 0.54%). bodily tax r ate is 19% (compared to 23% in UK, 29.65% in Germany and 33.3% in France)....